What is AARD's investment proceeds?

AARD (AARD) reported investment proceeds of $34.25M in Q1 2026.

How has AARD's investment proceeds changed year-over-year?

AARD's investment proceeds increased by 184.8% year-over-year, from $12.03M to $34.25M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

AARD AARD Investment Proceeds

Investment Proceeds at other companies

Relmada Therapeutics, Inc.RLMD

$14.29M-9.8%

Rhythm Pharmaceuticals, Inc.RYTM

$99.25M+70.1%

Viking TherapeuticsVKTX

$126.63M-57.2%

Protagonist TherapeuticsPTGX

$156.69M+38.4%

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's investment proceeds?: AARD (AARD) reported investment proceeds of $34.25M in Q1 2026.
How has AARD's investment proceeds changed year-over-year?: AARD's investment proceeds increased by 184.8% year-over-year, from $12.03M to $34.25M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.